Market's closed today, so the bashers are using their time to post absurd comments on Seeking Alpha. So that you don't have to go there (and give them the ad revenue they get every time we do visit), the current bashing premise is that focusing company resources on Brilacidin-OM, Brilacidin-UP, Prurisol, and Kevetrin-ovarian cancer trials was bad, that instead they should have spent a lot of money for the very long and complicated Brilacidin-ABSSI trial. Oh, and also there is no manipulation because "stock manipulation is hours, not months."

They must think that most readers are really stupid.